These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36309402)

  • 1. Membrane Active Immunomodulator As a Novel Therapy for an Infectious Bacterial Disease, Buruli Ulcer.
    Izbicka E; Streeper RT; Louden C
    In Vivo; 2022; 36(6):2615-2629. PubMed ID: 36309402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buruli ulcer and mycolactone-producing mycobacteria.
    Nakanaga K; Yotsu RR; Hoshino Y; Suzuki K; Makino M; Ishii N
    Jpn J Infect Dis; 2013; 66(2):83-8. PubMed ID: 23514902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of
    Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y
    Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
    Sarfo FS; Phillips RO; Zhang J; Abass MK; Abotsi J; Amoako YA; Adu-Sarkodie Y; Robinson C; Wansbrough-Jones MH
    BMC Infect Dis; 2014 Apr; 14():202. PubMed ID: 24731247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.
    Ogbechi J; Ruf MT; Hall BS; Bodman-Smith K; Vogel M; Wu HL; Stainer A; Esmon CT; Ahnström J; Pluschke G; Simmonds RE
    PLoS Pathog; 2015 Jul; 11(7):e1005011. PubMed ID: 26181660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
    Martins TG; Gama JB; Fraga AG; Saraiva M; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(2):e32740. PubMed ID: 22393444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
    Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.
    Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T
    Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.
    Doig KD; Holt KE; Fyfe JA; Lavender CJ; Eddyani M; Portaels F; Yeboah-Manu D; Pluschke G; Seemann T; Stinear TP
    BMC Genomics; 2012 Jun; 13():258. PubMed ID: 22712622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 17. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.
    Geroult S; Phillips RO; Demangel C
    J Wound Care; 2014 Aug; 23(8):417-8, 422-4. PubMed ID: 25139600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer.
    Akolgo GA; Partridge BM; D Craggs T; Amewu RK
    BMC Infect Dis; 2023 Jul; 23(1):495. PubMed ID: 37501134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.